SNYR: Utang jangka cendhak perusahaan Synergy CHC Corp.

Simbol lan logo merek synergychc.com (SNYR)

Synergy CHC Corp (SNYR) generates revenue by acquiring high-demand brands within the beauty segment. Short-term debt dynamics confirm financial stability, where 0.00 characterizes this valuation parameter. Growth is driven by digital marketing coupled with outsourced production, although intensifying online competition is gradually reducing cash flow, necessitating a revision of the current promotion strategy.

SNYR (synergychc.com) riwayat Utang jangka cendhak perusahaan saka 24.10.2024 nganti 03.10.2026
Produk seri Synergy CHC Corp

The stability of Synergy CHC Corp (SNYR) is underpinned by a diversified portfolio of health products, which mitigates the impact of consumer cyclicality when calculating liabilities. Analyzing the short-term debt profile with a value of 0.00, an investor assesses the total volume of payments due for repayment within a year, where the balance between liquidity and investment development directly determines the fair value of the business.

Perusahaan pesaing

HLN - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Jyong Bio|LGND (Ligand Pharmaceuticals) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan amneal.com|Kewajiban jangka cendhak perusahaan PRGO (Perrigo)|ALVO (Alvotech S.A.) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Utang jangka cendhak|ANIP: Kewajiban jangka cendhak perusahaan|mannkindcorp.com - Gedhene kewajiban jangka cendhak|AMPH: Utang jangka cendhak perusahaan|Pacira Pharmaceuticals - Silihan lan utang jangka cendhak perusahaan|SPRY (ARS Pharma) - Utang jangka cendhak perusahaan|Utang jangka cendhak Theravance Corp TBPH|Utang jangka cendhak perusahaan Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Tectonic Therapeutic TECX|Gunggunge utang jangka cendhak Tonix Pharma (TNXP)|SXTC: Kewajiban jangka cendhak perusahaan|Utang jangka cendhak Eupraxia Pharmaceuticals|BioHarvest Sciences (BHST) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan EXOZ|ORMP (Oramed) - Utang jangka cendhak perusahaan|Utang jangka cendhak Entera Bio Corp ENTX|Utang jangka cendhak perusahaan MindWalk (HYFT)|ABVC (ABVC BioPharma, Inc) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan CPIX (Cumberland Pharmaceuticals)|Tanggungan jangka cendhak quantumbiopharma.com|FGEN: Kewajiban jangka cendhak perusahaan|Utang jangka cendhak Telomir Pharmaceuticals Inc|RANI (ranitherapeutics.com) - Kewajiban jangka cendhak perusahaan|Rallybio - Silihan lan utang jangka cendhak perusahaan|LEXX (Lexaria Bioscience Corp) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan pulmatrix.com (PULM)|Utang jangka cendhak perusahaan PTHL|APM (aptorumgroup.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan LYRA (Lyra Therapeutics, Inc)|IBO - Kewajiban jangka cendhak perusahaan|TNFA: Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan YCBD (cbdMD, Inc.)|PRFX: Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Altamira Therapeutics Ltd.|Utang jangka cendhak perusahaan Lipella|Utang jangka cendhak OptiNose Corp OPTN|Utang jangka cendhak perusahaan Pieris Pharmaceuticals (PIRS)|PROC (procapsgroup.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Petros Pharmaceuticals, Inc. PTPI|QLI (Qilian International Holding Group) - Kewajiban jangka cendhak|SLRN - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak TFF Pharmaceuticals, Inc TFFP